INS and type 2 diabetes mellitus: A recent study analysing the effects of testosterone administration to 24 hypogondal men (10 treated with insulin) over the age of 30 years with type 2 diabetes found that testosterone replacement therapy reduced insulin resistance (as measured by homeostatic model index) and improved glycaemic control in hypogonadal men with type 2 diabetes (56).